BD (Becton, Dickinson and Company) announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics.

Aptar Pharma, a provider of drug delivery systems, has acquired all device technology assets from SipNose Nasal Delivery Systems’ portfolio, expanding its presence in the intranasal drug ...

TFF Pharmaceuticals, a clinical-stage company founded in 2018 and headquartered in Fort Worth, has about 10 employees and contractors working in North Carolina, mostly in the Raleigh area ...

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...

Cure Pharmaceutical is cashing in some of its drug delivery intellectual property, selling patents covering film-based drug delivery to TF Tech Ventures in a deal worth $20 million.. The deal ...

Almost 90% of pharmaceutical companies see smart inhalers and other digital drug delivery devices as very or extremely important to their future plans, according to a Molex survey.. Molex, which ...

West Pharmaceutical raised its annual profit forecast and trimmed its estimates for tariff impact on Thursday, sending the medical equipment maker's shares up 24% in early trading.

The solution cleanly presents itself, not in new process with increased reactivity, but through the consistent and structured application of the Agile growth mindset to transforming culture, ...

Tokyo, Japan and Cambridge, UK, 29 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new ...